Matches in SemOpenAlex for { <https://semopenalex.org/work/W2739631878> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2739631878 abstract "Preeclampsia is a gestational hypertensive disorder which occurs in 5-10% of all pregnancies in the US. While the underlying cause of the disease is unknown, there is growing recognition that placental ischemia leads to the secretion of pathogenic factors into the maternal blood stream, perhaps most notably the VEGF antagonist sFlt-1. Circulating sFlt-1 sequesters free VEGF and decreases the overall level of VEGF available for cell signaling. Preclinical experiments suggested a palliative effect of VEGF delivery in preeclampsia models, but translation of this therapy is severely hampered by the short half-life of free VEGF and convenient routes of administration. We have recently constructed a VEGF chimera fused to an Elastin Like Polypeptide (ELP) polymer with significantly increased in vivo half-life and stability which appears to retain full VEGF signaling activity. Importantly, we have preliminary evidence that the ELP fusion prevents placental translocation and fetal exposure, preventing harmful fetal effects. ELP-VEGF stimulated normalized HUVEC proliferation at 72hr was dose dependent from 1-100nM, and was equivalent to that of free VEGF (2 ± 0.25 for ELP-VEGF vs 1.94 ± 0.18 at 100nM, p<0.05 versus control for both). Free VEGF (20nM) induced tube formation by HUVECs (8.8 ± 2 vs 14.5 ± 3 tubes/field, p<0.05). Likewise ELP-VEGF significantly increased tube formation compared to control cells (p<0.05), and trended toward augmentation of tube formation versus VEGF alone (18.6 ±4 tubes per frame, p=0.07), though this did not reach significance. Finally, ELP-VEGF (50nM) stimulated HUVEC migration through matrigel (9.9 ± 0.7 vs 3.4 ± 0.3 cells/field, p<0.05) to a similar extent to free VEGF (8.4 ± 0.6 cells/field, p<0.05 vs control). Together, these data suggest that ELP-VEGF retains full VEGF signaling potential, which along with enhanced pharmacokinetic parameters could be a useful therapeutic for the restoration of VEGF signaling in the preeclamptic patient." @default.
- W2739631878 created "2017-08-08" @default.
- W2739631878 creator A5024088608 @default.
- W2739631878 creator A5031519477 @default.
- W2739631878 creator A5034262384 @default.
- W2739631878 date "2013-09-01" @default.
- W2739631878 modified "2023-09-24" @default.
- W2739631878 title "Abstract 544: Development of a Stabilized Bioactive VEGF Chimera for the Management of Preeclampsia" @default.
- W2739631878 doi "https://doi.org/10.1161/hyp.62.suppl_1.a544" @default.
- W2739631878 hasPublicationYear "2013" @default.
- W2739631878 type Work @default.
- W2739631878 sameAs 2739631878 @default.
- W2739631878 citedByCount "0" @default.
- W2739631878 crossrefType "journal-article" @default.
- W2739631878 hasAuthorship W2739631878A5024088608 @default.
- W2739631878 hasAuthorship W2739631878A5031519477 @default.
- W2739631878 hasAuthorship W2739631878A5034262384 @default.
- W2739631878 hasConcept C104317684 @default.
- W2739631878 hasConcept C126322002 @default.
- W2739631878 hasConcept C134018914 @default.
- W2739631878 hasConcept C16685009 @default.
- W2739631878 hasConcept C167734588 @default.
- W2739631878 hasConcept C172680121 @default.
- W2739631878 hasConcept C185592680 @default.
- W2739631878 hasConcept C2776953305 @default.
- W2739631878 hasConcept C2777025900 @default.
- W2739631878 hasConcept C2777218350 @default.
- W2739631878 hasConcept C2779234561 @default.
- W2739631878 hasConcept C30278631 @default.
- W2739631878 hasConcept C49039625 @default.
- W2739631878 hasConcept C54355233 @default.
- W2739631878 hasConcept C55493867 @default.
- W2739631878 hasConcept C71924100 @default.
- W2739631878 hasConcept C86803240 @default.
- W2739631878 hasConceptScore W2739631878C104317684 @default.
- W2739631878 hasConceptScore W2739631878C126322002 @default.
- W2739631878 hasConceptScore W2739631878C134018914 @default.
- W2739631878 hasConceptScore W2739631878C16685009 @default.
- W2739631878 hasConceptScore W2739631878C167734588 @default.
- W2739631878 hasConceptScore W2739631878C172680121 @default.
- W2739631878 hasConceptScore W2739631878C185592680 @default.
- W2739631878 hasConceptScore W2739631878C2776953305 @default.
- W2739631878 hasConceptScore W2739631878C2777025900 @default.
- W2739631878 hasConceptScore W2739631878C2777218350 @default.
- W2739631878 hasConceptScore W2739631878C2779234561 @default.
- W2739631878 hasConceptScore W2739631878C30278631 @default.
- W2739631878 hasConceptScore W2739631878C49039625 @default.
- W2739631878 hasConceptScore W2739631878C54355233 @default.
- W2739631878 hasConceptScore W2739631878C55493867 @default.
- W2739631878 hasConceptScore W2739631878C71924100 @default.
- W2739631878 hasConceptScore W2739631878C86803240 @default.
- W2739631878 hasIssue "suppl_1" @default.
- W2739631878 hasLocation W27396318781 @default.
- W2739631878 hasOpenAccess W2739631878 @default.
- W2739631878 hasPrimaryLocation W27396318781 @default.
- W2739631878 hasRelatedWork W157490348 @default.
- W2739631878 hasRelatedWork W1980725734 @default.
- W2739631878 hasRelatedWork W1996890384 @default.
- W2739631878 hasRelatedWork W1997481880 @default.
- W2739631878 hasRelatedWork W2027056516 @default.
- W2739631878 hasRelatedWork W2033060716 @default.
- W2739631878 hasRelatedWork W2040601756 @default.
- W2739631878 hasRelatedWork W2144718958 @default.
- W2739631878 hasRelatedWork W2146800298 @default.
- W2739631878 hasRelatedWork W2349817853 @default.
- W2739631878 hasRelatedWork W2388129206 @default.
- W2739631878 hasRelatedWork W2581278672 @default.
- W2739631878 hasRelatedWork W2606875972 @default.
- W2739631878 hasRelatedWork W2774445883 @default.
- W2739631878 hasRelatedWork W2793242321 @default.
- W2739631878 hasRelatedWork W2885874270 @default.
- W2739631878 hasRelatedWork W3039543009 @default.
- W2739631878 hasRelatedWork W3002182184 @default.
- W2739631878 hasRelatedWork W3099291517 @default.
- W2739631878 hasRelatedWork W3146717242 @default.
- W2739631878 hasVolume "62" @default.
- W2739631878 isParatext "false" @default.
- W2739631878 isRetracted "false" @default.
- W2739631878 magId "2739631878" @default.
- W2739631878 workType "article" @default.